Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism
Top Cited Papers
- 4 January 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Metabolism
- Vol. 3 (1), 21-32
- https://doi.org/10.1038/s42255-020-00317-z
Abstract
Metabolic transformation is a hallmark of cancer and a critical target for cancer therapy. Cancer metabolism and behaviour are regulated by cell-intrinsic factors as well as metabolite availability in the tumour microenvironment (TME). This metabolic niche within the TME is shaped by four tiers of regulation: (1) intrinsic tumour cell metabolism, (2) interactions between cancer cells and non-cancerous cells, (3) tumour location and heterogeneity and (4) whole-body metabolic homeostasis. Here, we define these modes of metabolic regulation and review how distinct cell types contribute to the metabolite composition of the TME. Finally, we connect these insights to understand how each of these tiers offers unique therapeutic potential to modulate the metabolic profile and function of all cells inhabiting the TME.Funding Information
- U.S. Department of Health & Human Services | National Institutes of Health (RO1CA213062)
This publication has 172 references indexed in Scilit:
- Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiationNature Immunology, 2013
- Metabolism of [U‐13C]glucose in human brain tumors in vivoNMR in Biomedicine, 2012
- The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue TypeCell Metabolism, 2012
- The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte ActivationImmunity, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Tumors as Organs: Complex Tissues that Interface with the Entire OrganismDevelopmental Cell, 2010
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010
- Genotyping and Expression Analysis of IDO2 in Human Pancreatic Cancer: A Novel, Active TargetJournal of the American College of Surgeons, 2009
- Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cellsEuropean Journal of Immunology, 2008
- Cancer Cell Metabolism: Warburg and BeyondCell, 2008